Recombinant interferon alpha (rIFN alpha-2b) may retard progression of early primary myelofibrosis.
R T
RT
Silver
K
K
Vandris
D018450:Disease Progression; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000473:pathology; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins